| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 250,582 | 253,395 | 290,125 | 364,689 | | Cost of Revenue | 187,724 | 188,948 | 218,943 | 144,843 | | | Gross Profit | 62,858 | 64,447 | 71,182 | 219,846 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,126 | 14,353 | 14,852 | 145,252 | | Non Recurring |
-
| 652 | (133,932) | 38 | | Others | 27,009 | 26,236 | 27,889 | 27,928 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,832 | 23,206 | 162,373 | 46,628 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 158,722 | 214 | 42 | (118) | | Earnings Before Interest And Taxes | (44,533) | 25,007 | 162,751 | 46,675 | | Interest Expense | (33,795) | 19,568 | 14,227 | 14,982 | | Income Before Tax | (10,738) | 5,439 | 148,524 | 31,693 | | Income Tax Expense | (195) | (516) | 100 | (408) | | Minority Interest | 39 | (100) |
-
| (147) | | | | Net Income From Continuing Ops | (5,049) | 5,855 | 148,424 | 31,789 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,504) | 5,855 | 148,424 | 31,789 | | Preferred Stock And Other Adjustments |
-
| 35 | (35) | 13,973 | | | Net Income Applicable To Common Shares | ($10,504) | $5,890 | $148,389 | $45,762 |
|
0.62% Nasdaq 
0.05%
Income Statement
